HUDSON TECHNOLOGIES INC /NY — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HUDSON TECHNOLOGIES INC /NY filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $237.12M | Mar 12, 2025 |
| FY2024 | Dec 31, 2023 | $289.03M | Mar 12, 2025 |
| FY2024 | Dec 31, 2022 | $325.23M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $192.75M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $147.61M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $162.06M | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | $25.72M | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | $40.55M | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | $57.83M | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | $42.43M | Mar 15, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.10M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $65.71M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $111.51M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $162.89M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $71.66M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $35.41M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $17.17M | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | $3.08M | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | $7.73M | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | ($26.08M) | Mar 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.67M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $24.39M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $52.25M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $103.80M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $32.26M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | ($5.21M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($25.94M) | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | ($8.11M) | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | ($13.88M) | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | ($30.62M) | Mar 15, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.56M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $29.30M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $78.17M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $131.51M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $42.31M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $5.90M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($15.78M) | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | ($3.90M) | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | ($369.0K) | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | ($37.43M) | Mar 15, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.24M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $33.02M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $30.54M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $28.59M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $26.57M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $26.64M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $30.02M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $32.27M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $21.75M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $11.65M | Mar 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.16M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $91.81M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $58.55M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $62.82M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | ($1.23M) | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $11.69M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $33.82M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $36.33M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $18.37M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $9.35M | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.05M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $5.30M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $3.58M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $3.66M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.92M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $1.47M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.01M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.09M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.02M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $1.73M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.65M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $302.65M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $296.67M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $272.49M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $215.72M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $161.65M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $180.15M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $228.34M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $321.44M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $122.47M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.26M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $56.80M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $67.90M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $97.62M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $144.78M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $121.03M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $135.04M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $159.13M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $197.99M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $10.45M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $243.39M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $245.85M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $228.77M | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | $174.88M | Mar 16, 2026 |
| FY2024 | Dec 31, 2021 | $70.94M | Mar 12, 2025 |
| FY2023 | Dec 31, 2020 | $40.62M | Mar 14, 2024 |
| FY2021 | Dec 31, 2019 | $45.11M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $69.21M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $123.45M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $112.02M | Mar 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.28M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $62.28M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $47.80M | Mar 16, 2026 |
| FY2023 | Dec 31, 2022 | $47.80M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $47.80M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $47.80M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $47.80M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $47.80M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $49.46M | Mar 15, 2019 |
| FY2017 | Oct 10, 2017 | $48.61M | Mar 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $151.28M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $134.62M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $110.23M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $57.98M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($45.82M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | ($78.08M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($72.87M) | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | ($46.93M) | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $8.73M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($2.43M) | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.46M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $70.13M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $12.45M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $5.30M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $3.49M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.35M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.60M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $2.27M | Mar 13, 2020 |
| FY2019 | Dec 31, 2017 | $5.00M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $33.93M | Mar 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $351.0K | Mar 10, 2017 |
| FY2016 | Dec 31, 2015 | $24.87M | Mar 10, 2017 |
| FY2015 | Dec 31, 2014 | $10.71M | Mar 11, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Mar 15, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 12, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Mar 15, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41.65M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 44.28M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 45.50M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 45.29M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 44.76M | Mar 14, 2023 |
| FY2020 | Dec 31, 2020 | 43.35M | Mar 12, 2021 |
| FY2020 | Dec 31, 2019 | 42.63M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | 42.60M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 42.40M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 41.47M | Mar 16, 2018 |